{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:02:02Z","timestamp":1791939722221,"version":"4.3.4"},"reference-count":50,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. bras. epidemiol."],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>RESUMEN:  Introducci\u00f3n:  La hepatitis C es uno de los grandes problemas de salud p\u00fablica en el mundo, especialmente por su alta transmisibilidad por v\u00eda inyectada.  Objetivo:  Identificar la prevalencia de la infecci\u00f3n por VHC, y factores asociados en usuarios de drogas psicoactivas inyectables en tres ciudades (Armenia, Bogot\u00e1 y C\u00facuta) de Colombia.  M\u00e9todos:  Estudio descriptivo transversal en 668 usuarios de drogas inyectables captados a trav\u00e9s de muestreo guiado por el respondiente, a quienes se indag\u00f3 sobre caracter\u00edsticas demogr\u00e1ficas y comportamientos de riesgo. Se utiliz\u00f3 la prueba de Anticuerpos, tomado en papel de filtro y se confirmaron los casos de VHC, con pruebas de carga viral de RNA. Se estim\u00f3 la prevalencia de VHC y los factores asociados con pruebas estad\u00edsticas Chi-cuadrado y se calcularon razones de prevalencia crudas y ajustadas con regresi\u00f3n log\u00edstica usando RDSAT y SPSS.  Resultados:  La prevalencia de infecci\u00f3n por VHC fue del 17,5% y se encontraron como factores que aumentan la prevalencia de hepatitis: tener VIH, inyectarse con otra persona portadora del virus, utilizar dosis de una jeringa que estaba compartiendo, inyectarse con una jeringa casera y consumir marihuana. Como factor que reduce la prevalencia, el adquirir jeringas en droguer\u00edas u otras tiendas.  Conclusi\u00f3n:  Se evidencia un consumo establecido de drogas por v\u00eda inyectada, poniendo de relieve la importancia de generar intervenciones para la reducci\u00f3n de da\u00f1os y la prevenci\u00f3n de hepatitis C en estas tres ciudades del pa\u00eds.<\/jats:p>","DOI":"10.1590\/1980-5497201700030007","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T17:48:40Z","timestamp":1510163320000},"page":"435-444","source":"Crossref","is-referenced-by-count":10,"title":["Uso de hero\u00edna inyectada y el riesgo de hepatitis C en tres ciudades de Colombia"],"prefix":"10.1590","volume":"20","author":[{"given":"Dedsy Yajaira","family":"Berbesi-Fern\u00e1ndez","sequence":"first","affiliation":[{"name":"Universidad CES,  Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Segura-Cardona","sequence":"additional","affiliation":[{"name":"Universidad CES,  Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana Patricia","family":"Montoya-Velez","sequence":"additional","affiliation":[{"name":"Universidad CES,  Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra \u00c1ngel","family":"Santamar\u00eda","sequence":"additional","affiliation":[{"name":"Universidad CES,  Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz JF","year":"2006","journal-title":"J Hepatol"},{"key":"ref2","series-title":"Viral hepatitis: WHA63.18","year":"2010"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah K","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"ref4","first-page":"674","article-title":"Hepatitis C virus infection. Epidemiology","volume":"43","author":"Bastie A","year":"1995","journal-title":"Pathol Biol (Paris)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1046\/j.1440-1746.2000.02134.x","article-title":"Public health challenges in hepatitis C virus infection","volume":"15","author":"Kaldor JM","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","article-title":"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis","volume":"26","author":"Smith DJ","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32833c11a5","article-title":"Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection","volume":"24","author":"van de Laar TJ","year":"2010","journal-title":"AIDS"},{"key":"ref8","series-title":"CircularHep_ByC.pdf"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","article-title":"Natural History of Hepatitis C","volume":"44","author":"Lingala S","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"issue":"471","key":"ref10","first-page":"896","article-title":"Hepatitis C: epidemiology natural course and diagnosis","volume":"11","author":"Moradpour D","year":"2015","journal-title":"Rev Med Suisse"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1743-422X-9-242","article-title":"Molecular characterization of hepatitis c virus in multi-transfused Colombian patients","volume":"9","author":"di Filippo D","year":"2012","journal-title":"Virol J"},{"key":"ref12","first-page":"S131","article-title":"Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors","volume":"3","author":"Nokhodian Z","year":"2012","journal-title":"Int J Prev Med"},{"issue":"4","key":"ref13","article-title":"Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?","volume":"6","author":"Alvarado-Mora MV","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11524-012-9728-0","article-title":"HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA","volume":"90","author":"Garfein RS","year":"2013","journal-title":"J Urban Health Bull N Y Acad Med"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/eurpub\/ckr083","article-title":"Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis","volume":"22","author":"Harris RJ","year":"2012","journal-title":"Eur J Public Health"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/cid\/cis393","article-title":"Evolving epidemiology of hepatitis C virus in the United States","volume":"55","author":"Klevens RM","year":"2012","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/09540120701426524","article-title":"Experience of hepatitis C testing among injecting drug users in Sydney, Australia","volume":"20","author":"Day CA","year":"2008","journal-title":"AIDS Care"},{"key":"ref18","first-page":"S156","article-title":"Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran","volume":"3","author":"Kassaian N","year":"2012","journal-title":"Int J Prev Med"},{"issue":"45","key":"ref19","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.3748\/wjg.15.5647","article-title":"Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors","volume":"15","author":"Waheed Y","year":"2009","journal-title":"World J Gastroenterol WJG"},{"key":"ref20","first-page":"1","article-title":"Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia","author":"Navas M-C","year":"2011","journal-title":"Hepat Res Treat"},{"issue":"2","key":"ref21","first-page":"232","article-title":"Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia","volume":"29","author":"Beltr\u00e1n M","year":"2009","journal-title":"Biom\u00e9d Rev Inst Nac Salud"},{"key":"ref22","first-page":"1","article-title":"Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia","author":"Cortes-Mancera F","year":"2011","journal-title":"Hepat Res Treat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S1386-6532(05)80032-0","article-title":"Hepatitis C virus seroprevalence in multi-transfused patients in Colombia","volume":"34","author":"Beltr\u00e2n M","year":"2005","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/1743-422X-8-345","article-title":"Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection","volume":"8","author":"Alvarado-Mora MV","year":"2011","journal-title":"Virol J"},{"key":"ref25","series-title":"Respondent Driven Sampling"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078402","article-title":"Respondent driven sampling: determinants of recruitment and a method to improve point estimation","volume":"8","author":"McCreesh N","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s10461-011-0032-x","article-title":"Respondent-Driven Sampling and the Recruitment of People with Small Injecting Networks","volume":"16","author":"Paquette D","year":"2012","journal-title":"AIDS Behav"},{"key":"ref28","series-title":"Prevalencia de VIH y comportamientos de riesgo en UDI en Medellin y Pereira","author":"Berbesi D","year":"2012"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.20882\/adicciones.373","article-title":"La inyecci\u00f3n de drogas en Bogot\u00e1: una amenaza creciente","volume":"17","author":"Mej\u00eda IE","year":"2005","journal-title":"Adicciones"},{"issue":"2","key":"ref30","first-page":"93","article-title":"Determinaci\u00f3n de anticuerpos al virus de la inmunodeficiencia humana tipo 1 (VIH-1) en muestras de sangre seca en papel de filtro","volume":"50","author":"P\u00e9rez Guevara MT","year":"1998","journal-title":"Rev Cubana Med Trop"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.20882\/adicciones.749","article-title":"Hepatitis C y VIH en usuarios de drogas inyectables en Armenia-Colombia","volume":"27","author":"Berbesi-Fern\u00e1ndez D","year":"2015","journal-title":"Adicciones"},{"issue":"4","key":"ref32","article-title":"Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?","volume":"6","author":"Alvarado-Mora MV","year":"2011","journal-title":"PLoS One"},{"key":"ref33","first-page":"364","article-title":"Cross-sectional study of HIV prevalence and the characteristics of injecting drug users in Colombia","author":"Berbesi D","year":"2013","journal-title":"J Subst Use"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10826084.2015.1092989","article-title":"Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV\/AIDS Prevention","volume":"51","author":"Mateu-Gelabert P","year":"2016","journal-title":"Subst Use Misuse"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.17711\/SM.0185-3325.2013.004","article-title":"Consumo de hero\u00edna inyectada en Colombia y comportamientos de riesgo","volume":"36","author":"Berbesi D","year":"2013","journal-title":"Salud Ment"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","DOI":"10.3855\/jidc.4525","article-title":"Hepatitis B and C prevalence among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Pereira, Colombia","volume":"8","author":"Sep\u00falveda-Arias JC","year":"2014","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"ref37","article-title":"Sexo transaccional en usuarios de drogas como factor de riesgo para infecciones de transmisi\u00f3n sexual","volume":"20","author":"Cruz I de A","year":"2014","journal-title":"Rev Sexol Soc"},{"key":"ref38","first-page":"45","article-title":"Prevalence of hepatitis C infection in injection drug users in Hong Kong","volume":"15","author":"Lee SS","year":"2009","journal-title":"Hong Kong Med J"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page K","year":"2009","journal-title":"J Infect Dis"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/infdis\/jiq111","article-title":"Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity","volume":"203","author":"Grebely J","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"ref41","first-page":"101","article-title":"Risk factors for hepatitis C among injecting drug users in Oslo","volume":"129","author":"Dalgard O","year":"2009","journal-title":"Tidsskr Nor L\u00e6geforen"},{"key":"ref42","first-page":"43","article-title":"Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil","volume":"43","author":"Lopes CLR","year":"2009","journal-title":"Rev Sa\u00fade P\u00fablica"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.20882\/adicciones.664","article-title":"Coca\u00ednas fumables en Latinoam\u00e9rica","volume":"12","author":"Casta\u00f1o G","year":"2000","journal-title":"Adicciones"},{"issue":"2","key":"ref44","article-title":"Consumo de basuco en usuarios de drogas inyectables de Colombia","volume":"42","author":"Berbesi Fernandez D","year":"2016","journal-title":"Rev Cuba Salud P\u00fablica"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(99)00094-0","article-title":"Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack","volume":"58","author":"Booth RE","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1503\/cmaj.082054","article-title":"Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs","volume":"181","author":"DeBeck K","year":"2009","journal-title":"Can Med Assoc J"},{"key":"ref47","first-page":"S73","article-title":"High risky behaviors among intravenous drug users in Isfahan, Iran: A study for hepatitis C harm reduction programs","volume":"3","author":"Hassannejad R","year":"2012","journal-title":"Int J Prev Med"},{"issue":"8","key":"ref48","first-page":"101","article-title":"Prevention of acquired immune deficiency syndrome (AIDS): report of inter-agency recommendations","volume":"32","year":"1983","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.drugpo.2014.08.014","article-title":"Prevention, treatment and care of hepatitis C virus infection among people who inject drugs","volume":"26","author":"Bruggmann P","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2007.04.004","article-title":"Global estimates of prevalence of HCV infection among injecting drug users","volume":"18","author":"Aceijas C","year":"2007","journal-title":"Int J Drug Policy"}],"container-title":["Revista Brasileira de Epidemiologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbepid\/v20n3\/1980-5497-rbepid-20-03-435.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T17:02:26Z","timestamp":1512579746000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1415-790X2017000300435&lng=es&tlng=es"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1415-790X2017000300435"],"URL":"https:\/\/doi.org\/10.1590\/1980-5497201700030007","relation":{},"ISSN":["1415-790X"],"issn-type":[{"value":"1415-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}